Evaluation of the Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of IN-C005 and IN-A001 in Healthy Caucasians

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

November 18, 2021

Study Completion Date

November 30, 2021

Conditions

Healthy

Interventions

DRUG

IN-C005 X mg

Oral capsule

DRUG

IN-A001 Y mg

Oral tablet

DRUG

IN-C005 Y mg

Oral capsule

DRUG

IN-C005 Z mg

Oral capsule

Trial Locations (2)

Seoul National University Hospital, Seoul

Seoul National University Hopsital, Seoul